Home > Insider Trading > Filing (0000919574-13-003753)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
876343	Biotime Inc	BTX	Biological Products, (No Disgnostic Substances) (2836)	943127919

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1278386	Broadwood Partners Lp	C/O Broadwood Capital Inc. 724 Fifth Avenue, 9Th Floor New York NY 10019	Yes	No	Yes	No
1278387	Broadwood Capital Inc	724 Fifth Avenue, 9Th Floor New York NY 10019	No	No	Yes	No
1278388	C Neal Bradsher	C/O Broadwood Capital Inc. 724 Fifth Avenue, 9Th Floor New York NY 10019	Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-06-04	200,000	$0.00	9,022,220	No	4	P	Direct
Common Stock	Acquisiton	2013-06-04	0	$0.00	9,022,220	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares	Option to Purchase Common Shares	Acquisiton	2013-06-04	50,000	$0.00	50,000	$5.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
50,000		2018-06-04	No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	42,908	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Shares	Option to Purchase Common Shares	$4.60	2017-06-30	20,000	20,000	Direct
Common Shares	Option to Purchase Common Shares	$5.13	2016-06-30	20,000	20,000	Direct
Common Shares	Option to Purchase Common Shares	$5.45	2015-08-09	20,000	20,000	Direct
Common Shares	Option to Purchase Common Shares	$2.30	2014-07-01	20,000	20,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2017-06-30	20,000	20,000	Direct
2016-06-30	20,000	20,000	Direct
2015-08-09	20,000	20,000	Direct
2014-07-01	20,000	20,000	Direct

Footnotes

The reported securities were purchased in a private transaction. Under the terms of the private transaction, Broadwood Partners, L.P. purchased 200,000 common shares and 50,000 options to purchase 50,000 common shares. Each common share and one quarter of each option were purchased for an aggregate price of $4.155.
These securities are owned by Broadwood Partners, L.P., which is a Reporting Person.
The reported securities are directly owned by Broadwood Partners, L.P. and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners, L.P. and Neal C. Bradsher as President of Broadwood Capital, Inc. Each of Broadwood Capital, Inc. and Neal C. Bradsher disclaim beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
These securities are owned by Neal C. Bradsher, who is a Reporting Person.
These options will vest and become exercisable in four quarterly installments, provided that Neal C. Bradsher remains a director on the last day of each quarter.
These options are exercisable immediately.